Maridea Wealth Management
XBI icon

Maridea Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Maridea Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$397K Buy
2,520
+369
+17% +$58.3K 0.04% 394
2026
Q2 		$340K Buy
2,151
+401
+23% +$54.2K 0.04% 388
2026
Q1 		$224K Buy
+1,750
New +$218K 0.03% 411

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Maridea Wealth Management's XBI Position: Q3 2026 in Review

Maridea Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 17% in Q3 2026, buying an estimated $58.3K and bringing the position to 2,520 shares worth $397K. The position accounts for 0.04% of the portfolio, ranked #394.

Maridea Wealth Management first reported a position in XBI in Q1 2026 and has held it in 3 quarters since. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Maridea Wealth Management held 2,520 shares of State Street SPDR S&P Biotech ETF worth $397K as of Q3 2026.
  • Maridea Wealth Management bought 369 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $58.3K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Maridea Wealth Management's portfolio in Q3 2026, its #394 holding.
  • Maridea Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 3 quarters since.
  • 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Maridea Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.